Quick Answer
UTAH MEDICAL PRODUCTS INC reported Gross Profit of $22.00 million for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -8.9% in Gross Profit from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $6.92 million | Q2 2018: $6.98 million | Q3 2018: $6.29 million | Q4 2018: $6.11 million | Q1 2019: $6.77 million | Q2 2019: $7.50 million | Q3 2019: $7.38 million | Q4 2019: $7.81 million | Q1 2020: $6.84 million | Q2 2020: $4.95 million | Q3 2020: $6.50 million | Q4 2020: $7.27 million | Q1 2021: $6.95 million | Q2 2021: $7.79 million | Q3 2021: $8.07 million | Q4 2021: $8.11 million | Q1 2022: $7.53 million | Q2 2022: $8.15 million | Q3 2022: $8.19 million | Q4 2022: $8.33 million | Q1 2023: $7.84 million | Q2 2023: $7.74 million | Q3 2023: $7.36 million | Q4 2023: $7.10 million | Q1 2024: $6.77 million | Q2 2024: $6.25 million | Q3 2024: $5.80 million | Q4 2024: $5.32 million | Q1 2025: $5.54 million | Q2 2025: $5.60 million | Q3 2025: $5.60 million | Q4 2025: $5.26 million.
- Over the full 17 years of available data (2009 to 2025), UTAH MEDICAL PRODUCTS INC's Gross Profit has grown by 59.6%.
- Historical annual values: Fiscal year 2025: $22.00 million | Fiscal year 2024: $24.14 million | Fiscal year 2023: $30.04 million | Fiscal year 2022: $32.20 million | Fiscal year 2021: $30.92 million | Fiscal year 2020: $25.55 million | Fiscal year 2019: $29.47 million | Fiscal year 2018: $26.31 million | Fiscal year 2017: $26.40 million | Fiscal year 2016: $23.69 million | Fiscal year 2015: $24.19 million | Fiscal year 2014: $24.98 million | Fiscal year 2013: $24.27 million | Fiscal year 2012: $25.31 million | Fiscal year 2011: $22.40 million | Fiscal year 2010: $13.21 million | Fiscal year 2009: $13.79 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: